IMMUPHARMA PLC — Remuneration Information 2016

Jun 2, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0951A

Immupharma PLC

02 June 2016

For Immediate Release                                                                                                                            2 June 2016

IMMUPHARMA PLC

Grant of Options

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, has today granted a total number of 1,600,000 share options to certain of its directors and employees representing 1.31% of ImmuPharma's Ordinary Shares and total voting rights. The exercise price for these options is 43.88 pence being the closing middle market share price on 1 June 2016. The options are exercisable between three and ten years from the date of grant.

The Company has adopted a HM Revenue & Customs approved share ownership plan (CSOP) and an unapproved share option scheme.

The amount of options granted to directors are summarised in the following table:

Director	Options Granted
Tim McCarthy	500,000
Franco di Muzio	100,000
Stephane Mery	100,000

Following this grant of options, the total number of share options outstanding will be 3,080,000 representing 2.53% of ImmuPharma's total voting rights.

-Ends-

For further information please contact:

ImmuPharma plc (www.immupharma.org)	+ 44 (0) 20 7152 4080
Tim McCarthy, Chairman
Lisa Baderoon, Head of Investor Relations Twitter: @immupharma	+ 44 (0) 7721 413 496
Panmure, Gordon & Co., NOMAD & Broker	+44 (0) 20 7886 2500
Fred Walsh, Duncan Monteith, Corporate Finance Charles Leigh-Pemberton, Corporate Broking

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHFTMFTMBTMBAF